Related Experiment Video
Updated: Aug 1, 2025

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death
Published on: October 31, 2017
Caffeic acid, but not ferulic acid, inhibits macrophage pyroptosis by directly blocking gasdermin D activation
Mingjiang Liu1,2,3, Dandan Liu2, Chenglong Yu2
1Beijing Key Laboratory of Basic Research With Traditional Chinese Medicine on Infectious Diseases Beijing Hospital of Traditional Chinese Medicine Capital Medical University Beijing China.
Abstract:
Regulated pyroptosis is critical for pathogen elimination by inducing infected cell rupture and pro-inflammatory cytokines secretion, while overwhelmed pyroptosis contributes to organ dysfunction and pathological inflammatory response. Caffeic acid (CA) and ferulic acid (FA) are both well-known antioxidant and anti-inflammatory phenolic acids, which resemble in chemical structure. Here we found that CA, but not FA, protects macrophages from both Nigericin-induced canonical and cytosolic lipopolysaccharide (LPS)-induced non-canonical pyroptosis and alleviates LPS-induced mice sepsis. It significantly improved the survival of pyroptotic cells and LPS-challenged mice and blocked proinflammatory cytokine secretion. The anti-pyroptotic effect of CA is independent of its regulations in cellular lipid peroxidation, mitochondrial function, or pyroptosis-associated gene transcription. Instead, CA arrests pyroptosis by directly associating with gasdermin D (GSDMD) and blocking its processing, resulting in reduced N-GSDMD pore construction and less cellular content release. In LPS-induced septic mice, CA inhibits GSDMD activation in peritoneal macrophages and reduces the serum levels of interleukin-1β and tumor necrosis factor-α as the known pyroptosis inhibitors, disulfiram and dimethyl fumarate. Collectively, these findings suggest that CA inhibits pyroptosis by targeting GSDMD and is a potential candidate for curbing the pyroptosis-associated disease.
Insights
Caffeic acid (CA) protects against pyroptosis, a cell death process linked to inflammation and organ damage. CA targets gasdermin D (GSDMD), offering a potential treatment for pyroptosis-associated diseases.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Pyroptosis is a crucial inflammatory cell death pathway involved in pathogen defense but can cause organ damage when dysregulated.
- Caffeic acid (CA) and ferulic acid (FA) are phenolic acids with known antioxidant and anti-inflammatory properties.
Purpose of the Study:
- To investigate the protective effects of CA and FA against pyroptosis and their therapeutic potential in sepsis.
- To elucidate the molecular mechanism underlying CA's anti-pyroptotic activity.
Main Methods:
- Macrophage cell models of canonical (Nigericin) and non-canonical (LPS) pyroptosis were used.
- Mice models of LPS-induced sepsis were employed.
- Molecular assays assessed CA's impact on pyroptosis markers, cellular functions, and gasdermin D (GSDMD) interaction.
Main Results:
- CA, but not FA, protected macrophages from pyroptosis and improved survival in LPS-challenged mice.
- CA significantly reduced pro-inflammatory cytokine secretion (IL-1β, TNF-α) in vitro and in vivo.
- CA directly binds to GSDMD, inhibiting its cleavage and pore formation, independent of lipid peroxidation, mitochondrial function, or gene transcription.
Conclusions:
- Caffeic acid (CA) effectively inhibits pyroptosis by directly targeting GSDMD, representing a novel therapeutic strategy.
- CA demonstrates potential for treating pyroptosis-associated diseases, including sepsis.

